Validation and Comparison of CS-IHC4 Scores with a Nomogram to Predict Recurrence in Hormone Receptor-Positive Breast Cancers

Publisher： Karger

E-ISSN： 1423-0232|86|5-6|279-288

ISSN： 0030-2414

Source： Oncology, Vol.86, Iss.5-6, 2014-06, pp. : 279-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apparent diffusion coefficient in estrogen receptor‐positive and lymph node‐negative invasive breast cancers at 3.0T DW‐MRI: A potential predictor for an oncotype Dx test recurrence score

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 47, Iss. 2, 2018-02 ,pp. : 401-409

John Wiley & Sons Inc

Access to resources Recommend Favorite

The 21-Gene Recurrence Score Assay (Oncotype DX™) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli Cohort

By  

Oncology, Vol. 87, Iss. 1, 2014-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

The Preoperative Neutrophil/Lymphocyte Ratio Does not Correlate with the 21-Gene Recurrence Score in Estrogen Receptor-Positive Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 38, Iss. 1-2, 2015-01 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

More treatment options for women with hormone receptor‐positive breast cancer: Guideline update, studies lead to advances in care

By  

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 2939-2940

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimizing Quality of Life in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Treatment Options and Considerations

By  

Oncology, Vol. 93, Iss. 3, 2017-06 ,pp. : 143-156

Karger

Access to resources Recommend Favorite